High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the... by Cissy Kityo, Diana M Gibb, Charles F Gilks, Ruth L Goodall, Ivan Mambule, Pontiano Kaleebu, Deenan Pillay, Ronnie Kasirye, Peter Mugyenyi, A Sarah Walker, David T Dunn, DART Trial Team

Get full text

Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial. by Sujal M Parikh, Ekwaro A Obuku, Sarah A Walker, Aggrey S Semeere, Brandon J Auerbach, James G Hakim, Harriet Mayanja-Kizza, Peter N Mugyenyi, Robert A Salata, Cissy M Kityo, DART Trial Team

Get full text

Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial. by Diana M Gibb, Hilda Kizito, Elizabeth C Russell, Ennie Chidziva, Eva Zalwango, Ruth Nalumenya, Moira Spyer, Dinah Tumukunde, Kusum Nathoo, Paula Munderi, Hope Kyomugisha, James Hakim, Heiner Grosskurth, Charles F Gilks, A Sarah Walker, Phillipa Musoke, DART trial team

Get full text

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe. by Antonieta Medina Lara, Jesse Kigozi, Jovita Amurwon, Lazarus Muchabaiwa, Barbara Nyanzi Wakaholi, Ruben E Mujica Mota, A Sarah Walker, Ronnie Kasirye, Francis Ssali, Andrew Reid, Heiner Grosskurth, Abdel G Babiker, Cissy Kityo, Elly Katabira, Paula Munderi, Peter Mugyenyi, James Hakim, Janet Darbyshire, Diana M Gibb, Charles F Gilks, DART Trial Team

Get full text